Hoth Therapeutics Inc (NASDAQ:HOTH) does about 8.76M shares in volume on a normal day but saw 10331392 shares change hands in the recent trading day. The company now has a market cap of 13.12M USD. Its current market price is $1.90, marking no change compared to the previous close of $1.90. The 52 week high reached by this stock is $3.80 whilst the lowest price level in 52 weeks is $0.58.
Hoth Therapeutics Inc (HOTH) has a 20-day trading average at $0.9798 and the current price is -50.00% off the 52-week high compared with 227.59% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.9060 and its 200-day simple moving average is $0.9640. If we look at the stock’s price movements over the week, volatility stands at 69.43%, which decreases to 21.82% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 74.96 to suggest the stock is overbought.
The consensus objective for the share price is $4.50, suggesting that the stock has a potential upside of 57.78% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 15, 2019 when The Benchmark Company initiated the stock to “Speculative Buy” and issued a price target of $10.
The current price level is 93.87%, 109.68%, and 97.10% away from its SMA20, SMA50, and SMA200 respectively, with the HOTH price moving below the 50-day SMA on current market day. Hoth Therapeutics Inc (HOTH) stock is up 146.72% over the week and 121.19% over the past month. Its price is 153.98% year-to-date and 40.74% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.26 and -1.9 for whole year.
To reach the target analysts have set, the stock logically needs to grow 57.78 percent from here.
Outstanding shares total 6.90M with insiders holding 0.93% of the shares and institutional holders owning 5.31% of the company’s common stock. The company has a return on investment of -100.14% and return on equity of -83.41%. The beta has a value of 0.68. Price to book ratio is 1.75.
